SPY003-207

· Spyre Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SPY003-207, covering 2026-03-20 to 2026-03-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study of SPY003-207 in Healthy Volunteers [Phase 1]